This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Corinna Link: Innovator in Immune Activation
Introduction
Corinna Link is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of immune activation through her innovative research and development efforts. Her work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Corinna Link holds a patent titled "Substituted Aminothiazoles as DGKzeta Inhibitors for Immune Activation." This patent highlights her innovative approach to enhancing immune responses, which could have important implications for therapeutic applications.
Career Highlights
Corinna Link is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. Her role at Bayer allows her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.
Collaborations
Throughout her career, Corinna has worked alongside notable colleagues, including Norbert Schmees and Ulrike Roehn. These collaborations have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Corinna Link's contributions to the field of immune activation through her patent and work at Bayer Aktiengesellschaft exemplify her commitment to innovation and scientific advancement. Her achievements reflect the importance of collaboration and dedication in the pursuit of groundbreaking discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile